Cephalogics, LLC will develop and commercialize a novel neuroimaging device employing a wearable imaging cap. This technology will represent a significant gain in terms of cost and ease of use over current technologies which use large, room-size scanners for mapping human brain function. It will support neuroimaging, continuous bedside imaging, and critical care monitoring.

Our patent-pending technology will be marketed to imaging manufacturers and hospitals worldwide.

Cephalogics’ technology is being developed by Dr. Joseph P. Culver at Washington University in St. Louis.

.:: LATEST NEWS
DOT sheds light on infant brains